- Who can participate: Adults aged 18 and older with specific health conditions are eligible. Key eligibility factors will be assessed during the screening process.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study will involve regular monitoring and assessments to gather comprehensive data on the treatment's effects.

